文献速递心力衰竭与心肌病

美国成人心脏移植候选者治疗的地域差异

Geographic Variation in the Treatment of U.S. Adult Heart Transplant Candidates.
PubMed 文献 · J Am Coll Cardiol · 2018-01-01

该研究基于2010至2015年SRTR登记的12,762例非心源性休克成人心脏移植候选者,定义「潜在过度治疗」为对不符合AHA心源性休克标准者使用大剂量正性肌力药或IABP。结果显示11.6%存在潜在过度治疗,中心间差异悬殊(最低四分位2.1% vs 最高四分位27.6%),且当地竞争≥2个中心使潜在过度治疗几率增加50%。

要点

  • 11.6%的非休克候选者接受了大剂量正性肌力药或IABP等潜在过度治疗。
  • 中心间潜在过度治疗率差异达25.5个百分点,调整候选者差异后不变。
  • 当地存在≥2个移植中心竞争时,潜在过度治疗几率增加50%。

核心结论

  • 成人心脏移植中心治疗实践差异大,供心竞争与血流动力学稳定候选者的潜在过度治疗相关,可能影响稀缺供心的公平高效分配。

研究设计与样本

  • 回顾性队列研究,纳入2010至2015年SRTR登记的12,762例非心源性休克成人心脏移植候选者,覆盖108个中心。
  • 采用多水平logistic回归和倾向评分模型调整各中心候选者差异。

主要发现

  • 1,471例(11.6%)候选者被潜在过度治疗,即不符合AHA心源性休克标准却使用大剂量正性肌力药或IABP。
  • 最低四分位中心潜在过度治疗率为2.1%,最高四分位为27.6%,四分位差25.5%(95%CI 21%至30%)。
  • 调整候选者差异后四分位差无显著改变。
  • 当地竞争≥2个中心使潜在过度治疗调整OR为1.50(95%CI 1.07至2.11)。

关键数值与推荐

  • 潜在过度治疗定义:不符合AHA心源性休克标准却使用大剂量正性肌力药或主动脉内球囊反搏。
  • 中心竞争定义为当地存在2个或以上移植中心。

临床怎么用

  • 心内科医生在评估心脏移植候选者时应严格参照AHA心源性休克标准,避免对血流动力学稳定者过度使用大剂量正性肌力药或IABP。
  • 应关注当地移植中心竞争格局对治疗决策的潜在影响,促进供心公平分配。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The current U.S. priority ranking for heart candidates is based on treatment intensity, not objective markers of severity of illness. This system may encourage centers to overtreat candidates. OBJECTIVES: This study sought to describe national variation in the intensity of treatment of adult heart transplantation candidates and identify center-level predictors of potential overtreatment. METHODS: The registrations of all U.S. adult heart transplantation candidates from 2010 to 2015 were collected from the SRTR (Scientific Registry of Transplant Recipients). "Potential overtreatment" was defined as treatment of a candidate who did not meet American Heart Association cardiogenic shock criteria with either high-dose inotropes or an intra-aortic balloon pump. Multilevel logistic regression and propensity score models were used to adjust for candidate variability at each center. Center-level variables associated with potential overtreatment were identified. RESULTS: From 2010 to 2015, 108 centers listed 12,762 adult candidates who were not in cardiogenic shock for heart transplantation. Of these, 1,471 (11.6%) were potentially overtreated with high-dose inotropes or intra-aortic balloon pumps. In the bottom quartile of centers, only 2.1% of candidates were potentially overtreated compared with 27.6% at top quartile centers, an interquartile difference of 25.5% (95% confidence interval: 21% to 30%). Adjusting for candidate differences did not significantly alter the interquartile difference. Local competition with 2 or more centers increased the odds of potential overtreatment by 50% (adjusted odds ratio: 1.50; 95% confidence interval: 1.07 to 2.11). CONCLUSIONS: There is wide variation in the treatment practices of adult heart transplantation centers. Competition for transplantable donor hearts is associated with the potential overtreatment of hemodynamically stable candidates. Overtreatment may compromise the fair and efficient allocation of scarce deceased donor hearts.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Parker WF, Anderson AS, Hedeker D, et al. Geographic Variation in the Treatment of U.S. Adult Heart Transplant Candidates. J Am Coll Cardiol. 2018. PMID: 29666020. doi:10.1016/j.jacc.2018.02.030

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。